|
Sign In to gain access to subscriptions and/or personal tools.
|
Carotid Plaque Morphologic Characteristics
Gilbert Aidinian, MD
Departments of Surgery, Veterans Affairs Medical Center, Walter Reed Army Medical Center; Washington, DC
Jonathan M. Weiswasser, MD
Departments of Surgery, Veterans Affairs Medical Center; Washington, DC
Subodh Arora, MD
Departments of Surgery, Veterans Affairs Medical Center, George Washington University; Washington, DC
Christopher J. Abularrage, MD
Departments of Surgery, Veterans Affairs Medical Center, Georgetown University; Washington, DC
Niten Singh, MD
Departments of Surgery, Veterans Affairs Medical Center; Washington, DC
Anton N. Sidawy, MD
Departments of Surgery, Veterans Affairs Medical Center, George Washington University, Georgetown University; Washington, DC
Carotid artery atherosclerosis is predominantly believed to mirror atherosclerosis elsewhere in the body. Endothelial injury results in expression of cell surface adhesion molecules with expression of sequence of genes involved in the inflammatory pathway and expression of proinflammatory cytokines. The combination of the inflammatory mediators and contribution by monocytes infiltrating the intima and vascular smooth muscle cell proliferation result in the development of atheromatous plaque with a lipid-rich necrotic core. Complications of these atheromatous plaques can lead to plaque instability, rupture, and subsequent hemorrhage or ulceration. The significant risk factors, characteristics associated with symptoms, and available diagnostic imaging modalities are also discussed with review of the relevant literature.
Key Words: atheromatous plaque proinflammatory cytokines vascular smooth muscle cells
References
- 1. Stroke statistics-2005. U.S. statistics. The Internet stroke center. www.strokecenter.org. Accessed Sept 4, 2005.
- 2. European Carotid Surgery Trialists' Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351:1379-1387, 1998.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995.[Abstract/Free Full Text]
- 4. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 345:209-212, 1995.[Web of Science][Medline]
[Order article via Infotrieve]
- 5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 325:445-453, 1991.[Abstract]
- 6. European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (80-99%) or with mild (0-29%) carotid stenosis. Lancet 337:1235-1243, 1991.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 7. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1333-1445, 1994.[Medline]
[Order article via Infotrieve]
- 8. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126, 1999.[Free Full Text]
- 9. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 64:5-15, 1991.[Web of Science][Medline]
[Order article via Infotrieve]
- 10. O'Brien KD, McDonald TO, Chait A, et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-I in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996.[Abstract/Free Full Text]
- 11. Hansson GK, Jonasson L, Seifert PS, et al. Immune mechanisms in atherosclerosis. Arteriosclerosis 9:567-578, 1989.[Abstract/Free Full Text]
- 12. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A 92:3849-3853, 1995.[Abstract/Free Full Text]
- 13. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994.[Web of Science][Medline]
[Order article via Infotrieve]
- 14. Loftus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40-47, 2000.[Abstract/Free Full Text]
- 15. Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396-399, 1997.[Abstract/Free Full Text]
- 16. Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81:448-454, 1997.[Abstract/Free Full Text]
- 17. Haberland ME, Fong D, Cheng L. Malondialdehydealtered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241:215-218, 1988.[Abstract/Free Full Text]
- 18. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989.[Web of Science][Medline]
[Order article via Infotrieve]
- 19. Itabe H, Takeshima E, Iwasaki H, et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 269:15274-15279, 1994.[Abstract/Free Full Text]
- 20. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22:1162-1167, 2002.[Abstract/Free Full Text]
- 21. Manttari M, Manninen V, Huttunen JK, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 15:1599-1603, 1994.[Abstract/Free Full Text]
- 22. Nievelstein-Post P, Mottino G, Fogelman A, et al. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb 14:1151-1161, 1994.[Abstract/Free Full Text]
- 23. Liao F, Andalibi A, deBeer FC, et al. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579, 1993.[Web of Science][Medline]
[Order article via Infotrieve]
- 24. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101, 1990.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 25. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254-257, 1990.[CrossRef][Medline]
[Order article via Infotrieve]
- 26. Cushing SD, Fogelman AM. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb 12:78-82, 1992.[Abstract/Free Full Text]
- 27. Reid VC, Mitchinson MJ. Toxicity of oxidized low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 98:17-24, 1993.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 28. Heery JM, Kozak M, Stafforini DM, et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96:2322-2330, 1995.[Web of Science][Medline]
[Order article via Infotrieve]
- 29. Fuster V, Stein B, Ambrose JA, et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82(3 Suppl):II47-II59, 1990.[Medline]
[Order article via Infotrieve]
- 30. Carr SC, Farb A, Pearce WH, et al. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122:757-763; discussion, 763-4, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 31. Geng YJ, Wu Q, Muszynski M, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16:19-27, 1996.[Abstract/Free Full Text]
- 32. Kockx MM, Herman AG. Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 19:G23-G28, 1998.[Web of Science][Medline]
[Order article via Infotrieve]
- 33. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 181:93-99, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 34. Burleigh MC, Briggs AD, Lendon CL, et al. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis 96:71-81, 1992.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 35. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69:377-381, 1993.[Abstract/Free Full Text]
- 36. Fei H, Berliner JA, Parhami F, et al. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 13:1711-1717, 1993.[Abstract/Free Full Text]
- 37. Jander S, Sitzer M, Wendt A, et al. Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke 32:850-854, 2001.[Abstract/Free Full Text]
- 38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 363:801-809, 1993.
- 39. Zarins CK, Giddens DP, Bharadvaj BK, et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 53:502-514, 1983.[Abstract/Free Full Text]
- 40. Glagov S, Zarins C, Giddens DP, et al. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 112:1018-1031, 1988.[Web of Science][Medline]
[Order article via Infotrieve]
- 41. Chambers BR, Norris JW. Outcome on patients with asymptomatic neck bruits. N Engl J Med 315:860-865, 1986.[Abstract]
- 42. O'Holleran LW, Kennelly MM, McClurken M, et al. Natural history of asymptomatic carotid plaque. Five-year follow-up study. Am J Surg 154:659-662, 1987.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 43. Shaalan WE, Cheng H, Gewertz B, et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg 40:262-269, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 44. Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 15:605-613, 1984.[Abstract/Free Full Text]
- 45. Persson AV, Robichaux WT, Silverman M. The natural history of carotid plaque development. Arch Surg 118:1048-1052, 1983.[Abstract/Free Full Text]
- 46. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke 31:774-781, 2000.[Abstract/Free Full Text]
- 47. Gronholdt ML, Wiebe BM, Laursen H, et al. Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg 14:439-445, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 48. Patel MR, Kuntz KM, Klufas RA, et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 26:1753-1758, 1995.[Abstract/Free Full Text]
- 49. Rothwell PM, Salinas R, Ferrando LA, et al. Does the angiographic appearance of a carotid stenosis predict the risk of stroke independently of the degree of stenosis? Clin Radiol 50:830-833, 1995.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 50. Eliasziw M, Streifler JY, Fox AJ, et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Stroke 25:304-308, 1994.[Abstract]
- 51. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105:2708-2711, 2002.[Abstract/Free Full Text]
Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 18, No. 1,
63-70 (2006)
DOI: 10.1177/153100350601800124

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|